FDA 483 - David J Cahn, M.D. - June 27, 2023

An FDA inspection of David J Cahn, M.D., a clinical investigator in Lakewood, CO, revealed significant deficiencies in the conduct of clinical investigations. The firm failed to adhere to investigational plans by not reporting all adverse events and did not maintain adequate and accurate case histories. These issues indicate a lack of control over critical aspects of clinical trial management.